Natural killer cells (NK) have originally been defined as mediators of spontaneous cytotoxicity against virus-infected and tumor cells. In human peripheral blood the majority of NK cells can mediate cell lysis via perforin. Our preliminary data show that the majority of NK cells in human secondary lymphoid organs are immunoregulatory by secreting cytokines immediately after activation. Within one week after activation they, in addition, mature to the phenotype of peripheral blood cytotoxic NK cells and probably leave the secondary lymphoid tissues. Dendritic cells (DCs) are the primary antigen presenting cells that initiate adaptive immunity and we as well as other groups have recently demonstrated that DCs activate peripheral blood NK cells efficiently. Since DCs home rapidly to secondary lymphoid organs upon maturation and our preliminary data demonstrate that they activate NK cells in these tissues, we propose that DCs are the principal mediators of NK activation prior to T cell responses. In addition, we propose that secondary lymphoid tissues are the main site of this early NK activation. Early NK activation has been shown crucial in limiting viremia and tumor burden during successful immune responses. Based on these observations we propose to: 1. Identify DC subsets and maturation stimuli which optimally stimulate NK cells in secondary lymphoid organs. We will address proliferation and cytokine secretion of NK cells in secondary lymphoid organs after stimulation with in vitro generated DC subtypes and DCs of secondary lymphoid organs after maturation with DC subtype specific maturation stimuli. 2. Characterize DC derived signals for NK maturation in secondary lymphoid organs. We will test DC derived IL-15 and IL-12 for KIR upregulation, induction of cytokine secretion as well as cytotoxicity and migratory behavior by NK cells of secondary lymphoid organs. 3. Determine the role of DC mediated NK activation for polarization of T cell responses in secondary lymphoid organs. We will investigate the effect of NK activation in secondary lymphoid organs on DC maturation and alloreactive as well as EBV specific T cell polarization.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA108609-03
Application #
7087064
Study Section
Cancer Immunopathology and Immunotherapy Study Section (CII)
Program Officer
Howcroft, Thomas K
Project Start
2004-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2008-06-30
Support Year
3
Fiscal Year
2006
Total Cost
$270,647
Indirect Cost
Name
Rockefeller University
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Fonteneau, Jean Francois; Brilot, Fabienne; Münz, Christian et al. (2016) The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer. J Immunol 196:64-71
Jung, Jae; Münz, Christian (2015) Immune control of oncogenic ?-herpesviruses. Curr Opin Virol 14:79-86
Salguero, Gustavo; Daenthanasanmak, Anusara; Münz, Christian et al. (2014) Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation. J Immunol 192:4636-47
Jandus, Camilla; Boligan, Kayluz Frias; Chijioke, Obinna et al. (2014) Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest 124:1810-20
Azzi, Tarik; Lünemann, Anna; Murer, Anita et al. (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124:2533-43
Leung, Carol S; Maurer, Michael A; Meixlsperger, Sonja et al. (2013) Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. Blood 121:1584-94
Gannage, Monique; da Silva, Rosa Barreira; Münz, Christian (2013) Antigen processing for MHC presentation via macroautophagy. Methods Mol Biol 960:473-488
Chijioke, Obinna; Müller, Anne; Feederle, Regina et al. (2013) Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep 5:1489-98
Lünemann, Anna; Vanoaica, Liliana D; Azzi, Tarik et al. (2013) A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol 191:4989-95
Jungraithmayr, Wolfgang; Codarri, Laura; Bouchaud, Gregory et al. (2013) Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med 187:1349-59

Showing the most recent 10 out of 81 publications